266 related articles for article (PubMed ID: 30050996)
1. Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma.
Pascale RM; Feo CF; Calvisi DF; Feo F
Transl Gastroenterol Hepatol; 2018; 3():36. PubMed ID: 30050996
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
3. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
[TBL] [Abstract][Full Text] [Related]
4. Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.
Pascale RM; Peitta G; Simile MM; Feo F
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31234428
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting
Simile MM; Peitta G; Tomasi ML; Brozzetti S; Feo CF; Porcu A; Cigliano A; Calvisi DF; Feo F; Pascale RM
Oncotarget; 2019 Apr; 10(29):2835-2854. PubMed ID: 31073374
[TBL] [Abstract][Full Text] [Related]
6. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.
Calvisi DF; Simile MM; Ladu S; Pellegrino R; De Murtas V; Pinna F; Tomasi ML; Frau M; Virdis P; De Miglio MR; Muroni MR; Pascale RM; Feo F
Int J Cancer; 2007 Dec; 121(11):2410-20. PubMed ID: 17680562
[TBL] [Abstract][Full Text] [Related]
7. Methionine adenosyltransferases in liver cancer.
Murray B; Barbier-Torres L; Fan W; Mato JM; Lu SC
World J Gastroenterol; 2019 Aug; 25(31):4300-4319. PubMed ID: 31496615
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
9. New insights on the role of epigenetic alterations in hepatocellular carcinoma.
Frau M; Feo CF; Feo F; Pascale RM
J Hepatocell Carcinoma; 2014; 1():65-83. PubMed ID: 27508177
[TBL] [Abstract][Full Text] [Related]
10. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells.
Cai J; Mao Z; Hwang JJ; Lu SC
Cancer Res; 1998 Apr; 58(7):1444-50. PubMed ID: 9537246
[TBL] [Abstract][Full Text] [Related]
12. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
Pascale RM; Simile MM; Feo F
Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
[TBL] [Abstract][Full Text] [Related]
13. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
[TBL] [Abstract][Full Text] [Related]
14. Role of lncRNAs as prognostic markers of hepatic cancer and potential therapeutic targeting by S-adenosylmethionine via inhibiting PI3K/Akt signaling pathways.
Sadek KM; Lebda MA; Nasr NE; Nasr SM; El-Sayed Y
Environ Sci Pollut Res Int; 2018 Jul; 25(20):20057-20070. PubMed ID: 29748795
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressive effect of S-adenosylmethionine supplementation in a murine model of inflammation-mediated hepatocarcinogenesis is dependent on treatment longevity.
Stoyanov E; Mizrahi L; Olam D; Schnitzer-Perlman T; Galun E; Goldenberg DS
Oncotarget; 2017 Dec; 8(62):104772-104784. PubMed ID: 29285212
[TBL] [Abstract][Full Text] [Related]
16. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.
Tomasi ML; Iglesias-Ara A; Yang H; Ramani K; Feo F; Pascale MR; Martínez-Chantar ML; Mato JM; Lu SC
Gastroenterology; 2009 Mar; 136(3):1025-36. PubMed ID: 18983843
[TBL] [Abstract][Full Text] [Related]
17. Role of abnormal methionine metabolism in alcoholic liver injury.
Lu SC; Tsukamoto H; Mato JM
Alcohol; 2002 Jul; 27(3):155-62. PubMed ID: 12163143
[TBL] [Abstract][Full Text] [Related]
18. Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.
Tomasi ML; Ryoo M; Ramani K; Tomasi I; Giordano P; Mato JM; Lu SC
Oncotarget; 2015 Nov; 6(35):37706-23. PubMed ID: 26416353
[TBL] [Abstract][Full Text] [Related]
19. HP1s modulate the S-Adenosyl Methionine synthesis pathway in liver cancer cells.
Mancini M; Papon L; Mangé A; Cammas F; Fabbrizio E
Biochem J; 2020 Mar; 477(5):1033-1047. PubMed ID: 32091571
[TBL] [Abstract][Full Text] [Related]
20. Methionine adenosyltransferases in liver health and diseases.
Ramani K; Lu SC
Liver Res; 2017 Sep; 1(2):103-111. PubMed ID: 29170720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
